Concepedia
Statistics
Publications
6
Citations
863
H-Index
Active since
2003
Affiliations
University of Leeds(Current)
NIHR Leeds Musculoskeletal Biomedical Research Unit
Leeds Teaching Hospitals NHS Trust
James Cook University Hospital
Newcastle University
Kamran Naraghi is an author at University of Leeds specializing in medicine, osteoporosis, and bone health.
Top concepts
MedicineNursingImmunologyBone HealthOrthopedicsInflammationOsteoporosisPrimary CareRheumatologyTuberculosis
Publications per year
2003–2020
Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis
Jacob M. van Laar, Dominique Farge, Jacob K. Sont et al. · JAMA · 2014 · 725 citations · Full text
Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, results from an exploratory, prospective study
Gillian Wheater, Mohsen Elshahaly, Kamran Naraghi et al. · PLoS ONE · 2018 · 37 citations · Full text
Inflammation, Rheumatology, Bone Disease +15
Alternative tumour necrosis factor inhibitors (TNFi) or abatacept or rituximab following failure of initial TNFi in rheumatoid arthritis: the SWITCH RCT
Sarah Brown, Colin Everett, Kamran Naraghi et al. · Health Technology Assessment · 2018 · 33 citations · Full text
Pragmatic randomised controlled trial of very early etanercept and MTX versus MTX with delayed etanercept in RA: the VEDERA trial
Paul Emery, Sarah Horton, Raluca B Dumitru et al. · Annals of the Rheumatic Diseases · 2020 · 30 citations · Full text
LB0002 The astis trial: Autologous stem cell transplantation versus IV pulse cyclophosphamide in poor prognosis systemic sclerosis, first results
Jacob M. van Laar, Dominique Farge, Jacob K. Sont et al. · Annals of the Rheumatic Diseases · 2012 · 22 citations
1–5 of 6